Menu
GeneBe

rs139596860

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000032.5(ALAS2):c.1757A>T(p.Tyr586Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000399 in 1,205,917 control chromosomes in the GnomAD database, including 1 homozygotes. There are 141 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., 67 hem., cov: 23)
Exomes 𝑓: 0.00024 ( 1 hom. 74 hem. )

Consequence

ALAS2
NM_000032.5 missense

Scores

3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1O:1

Conservation

PhyloP100: 0.262
Variant links:
Genes affected
ALAS2 (HGNC:397): (5'-aminolevulinate synthase 2) The product of this gene specifies an erythroid-specific mitochondrially located enzyme. The encoded protein catalyzes the first step in the heme biosynthetic pathway. Defects in this gene cause X-linked pyridoxine-responsive sideroblastic anemia. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068839192).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00195 (217/111123) while in subpopulation AFR AF= 0.00668 (204/30557). AF 95% confidence interval is 0.00593. There are 0 homozygotes in gnomad4. There are 67 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd at 57 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ALAS2NM_000032.5 linkuse as main transcriptc.1757A>T p.Tyr586Phe missense_variant 11/11 ENST00000650242.1
ALAS2NM_001037968.4 linkuse as main transcriptc.1718A>T p.Tyr573Phe missense_variant 11/11
ALAS2NM_001037967.4 linkuse as main transcriptc.1646A>T p.Tyr549Phe missense_variant 10/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ALAS2ENST00000650242.1 linkuse as main transcriptc.1757A>T p.Tyr586Phe missense_variant 11/11 NM_000032.5 P1P22557-1
ALAS2ENST00000396198.7 linkuse as main transcriptc.1718A>T p.Tyr573Phe missense_variant 11/115 P22557-4
ALAS2ENST00000335854.8 linkuse as main transcriptc.1646A>T p.Tyr549Phe missense_variant 10/102 P22557-2
ALAS2ENST00000498636.1 linkuse as main transcriptc.*55A>T 3_prime_UTR_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.00185
AC:
206
AN:
111072
Hom.:
0
Cov.:
23
AF XY:
0.00171
AC XY:
57
AN XY:
33298
show subpopulations
Gnomad AFR
AF:
0.00633
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00114
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000672
GnomAD3 exomes
AF:
0.000563
AC:
97
AN:
172239
Hom.:
0
AF XY:
0.000310
AC XY:
18
AN XY:
58151
show subpopulations
Gnomad AFR exome
AF:
0.00645
Gnomad AMR exome
AF:
0.000564
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000577
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000131
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000241
AC:
264
AN:
1094794
Hom.:
1
Cov.:
30
AF XY:
0.000205
AC XY:
74
AN XY:
360564
show subpopulations
Gnomad4 AFR exome
AF:
0.00671
Gnomad4 AMR exome
AF:
0.000459
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000113
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000119
Gnomad4 OTH exome
AF:
0.00104
GnomAD4 genome
AF:
0.00195
AC:
217
AN:
111123
Hom.:
0
Cov.:
23
AF XY:
0.00201
AC XY:
67
AN XY:
33359
show subpopulations
Gnomad4 AFR
AF:
0.00668
Gnomad4 AMR
AF:
0.00114
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000664
Alfa
AF:
0.000435
Hom.:
2
Bravo
AF:
0.00210
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00808
AC:
31
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000717
AC:
87

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 25, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJul 05, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 30, 2016The Y586F variant has previously been reported as heterozygous in a single female patient with moderate congenital erythropoietic porphyria (To-Figueras et al., 2011). Functional analysis of Y586F found that it is assocaited with only a mild gain of function in vitro (To-Figueras et al., 2011). However, the NHLBI Exome Sequencing Project reports Y586F was observed in 31/3835 alleles from individuals of African-American background, indicating it may be a rare, benign variant in this population. The Y586F variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
X-linked sideroblastic anemia 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
X-linked erythropoietic protoporphyria Other:1
not provided, no classification providedliterature onlyGeneReviews-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
Cadd
Benign
16
Dann
Benign
0.87
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.81
T;.;T;T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.0069
T;T;T;T
MetaSVM
Uncertain
-0.093
T
MutationTaster
Benign
0.90
N;N;N
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.89
N;.;N;N
REVEL
Benign
0.28
Sift
Benign
0.085
T;.;T;T
Sift4G
Benign
0.20
T;.;T;T
Polyphen
0.016
.;B;B;.
Vest4
0.15
MVP
0.83
MPC
0.45
ClinPred
0.0035
T
GERP RS
4.2
Varity_R
0.17
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139596860; hg19: chrX-55035620; API